GlassScriptPhysician profile
Mark Rose
NPI 1790871804
$9,038.70
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,626 · 2020: $5,676 · 2021: $246 · 2022: $1,414 · 2023: $77.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collagen Matrix, INC | $5,600.00 | 2020 | |
| Kairos Surgical INC | $2,621.54 | 2019-2022 | |
| Smith+Nephew, INC. | $383.82 | 2019-2023 | Stravix Pl, Grafix Pl |
| Teva Pharmaceuticals USA, INC. | $145.65 | 2020-2022 | |
| Misonix INC | $86.16 | 2021 | |
| Axogen | $47.71 | 2022 | |
| Pacira Therapeutics, INC. | $47.59 | 2019-2020 | |
| Stryker Corporation | $38.41 | 2019-2022 | |
| Osteomed LLC | $29.53 | 2021 | |
| Averitas Pharma INC. | $20.34 | 2023 | Qutenza |
| Acumed LLC | $11.21 | 2019 | |
| Organogenesis INC. | $6.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.